Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Aug 11, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a multi-site research study including sites of both the University of Massachusetts Chan Medical School (UMass Memorial Healthcare System) and the University of Michigan Medical Center (Michigan).
Baseline call: During the baseline call, the investigators will obtain verbal informed consent. During the call, the investigators will also collect demographic information and measure health literacy, the latter using two validated single-item instruments the investigators have used before.
Randomization: The investigators will randomize patients to watch videos the investigators develo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • African-American patients aged 18 or older with elevated stroke risk (CHA2DS2-VASc ≥2 for men and ≥3 for women) who are not currently on anticoagulation (AC) but for whom a cardiology provider or primary care provider at the two study sites recommended AC recently
- Exclusion Criteria:
- • Non-African American and other non-Black patients under the age of 18 patients without an ICD-10 diagnostic code consistent with AF or atrial fibrillation or atrial flutter
- • Patient without a visit with a primary care provider, cardiovascular medicine specialist, or ambulatory care provider in the previous one year
- • Patient who is pregnant or a prisoner.
- • Patients with left atrial appendage surgery or device, hospice status, ongoing bleeding, and intracranial bleeding in intralobar territory
About University Of Massachusetts, Worcester
The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Worcester, Massachusetts, United States
Jacksonville, Florida, United States
Worcester, Massachusetts, United States
Patients applied
Trial Officials
Alok Kapoor, MD
Principal Investigator
UMass Chan Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported